| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |